Published in Time on September 13, 2010
Rates and risk factors for prolonged opioid use after major surgery: population based cohort study. BMJ (2014) 3.06
Prescription opioid analgesics increase the risk of depression. J Gen Intern Med (2013) 1.37
A community prevention model to prevent children from inhaling and ingesting harmful legal products. Eval Program Plann (2011) 0.80
Statins and cancer risk: a meta-analysis. JAMA (2006) 6.28
Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. JAMA (2004) 2.86
Neurothrombectomy devices for the treatment of acute ischemic stroke: state of the evidence. Ann Intern Med (2011) 2.28
Impact of statin dosing intensity on transaminase and creatine kinase. Am J Med (2007) 2.15
Cost-effectiveness of rivaroxaban compared to warfarin for stroke prevention in atrial fibrillation. Am J Cardiol (2012) 1.79
Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease. Ann Intern Med (2009) 1.62
Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation (2005) 1.56
Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. J Thorac Cardiovasc Surg (2008) 1.55
Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation. Europace (2009) 1.45
A comparison of two individual amiodarone regimens to placebo in open heart surgery patients. Ann Thorac Surg (2002) 1.43
Association between statin use and mortality in patients with implantable cardioverter-defibrillators and left ventricular systolic dysfunction. Heart Rhythm (2007) 1.42
Therapeutic hypothermia is associated with improved neurologic outcome and survival in cardiac arrest survivors of non-shockable rhythms. Resuscitation (2011) 1.41
Fortuitous therapeutic effect of Taser shock for a patient in atrial fibrillation. Ann Emerg Med (2008) 1.39
Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials. J Hypertens (2008) 1.35
The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials. Curr Med Res Opin (2008) 1.18
Effect of cinnamon on glucose control and lipid parameters. Diabetes Care (2007) 1.17
Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis. BMC Fam Pract (2012) 1.07
Staying healthy. A public mess. Time (2002) 1.06
The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail (2006) 1.02
Moxifloxacin and torsade de pointes. Ann Pharmacother (2007) 0.98
Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II). Circulation (2003) 0.97
Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III. Eur J Cardiothorac Surg (2007) 0.97
Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review. Pharmacotherapy (2012) 0.96
Electromagnetic Interference (EMI) and arrhythmic events in ICD patients undergoing gastrointestinal procedures. Pacing Clin Electrophysiol (2007) 0.95
Electrocardiographic and hemodynamic effects of Panax ginseng. Ann Pharmacother (2002) 0.94
Why we worry about the things we shouldn't...and ignore the things we should. Time (2006) 0.94
Novel anticoagulants for stroke prevention in atrial fibrillation: a systematic review of cost-effectiveness models. PLoS One (2013) 0.93
Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis. Eur J Cardiothorac Surg (2009) 0.91
The association among blood transfusions, white blood cell count, and the frequency of post-cardiothoracic surgery atrial fibrillation: a nested cohort study from the Atrial Fibrillation Suppression Trials I, II, and III. J Cardiothorac Vasc Anesth (2008) 0.90
Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord (2008) 0.89
Impact of fluid balance on incidence of atrial fibrillation after cardiothoracic surgery. Am J Cardiol (2004) 0.88
Effect of perioperative corticosteroid use on the incidence of postcardiothoracic surgery atrial fibrillation and length of stay. Heart Rhythm (2006) 0.88
Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis. J Thorac Cardiovasc Surg (2010) 0.87
Evaluating the safety implications of aprotinin use: the Retrospective Evaluation of Aprotinin in Cardio Thoracic Surgery (REACTS). J Thorac Cardiovasc Surg (2007) 0.87
Effects of ischemia on repolarization in patients with single and multivessel coronary disease. Pacing Clin Electrophysiol (2003) 0.86
Indicators of atrial fibrillation risk in cardiac surgery patients on prophylactic amiodarone. Ann Thorac Surg (2004) 0.85
Impact of prophylactic postoperative beta-blockade on post-cardiothoracic surgery length of stay and atrial fibrillation. Ann Pharmacother (2004) 0.85
The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators. Heart Rhythm (2010) 0.85
Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis. Am J Health Syst Pharm (2006) 0.85
Impact of epicardial anterior fat pad retention on postcardiothoracic surgery atrial fibrillation incidence: the AFIST-III Study. J Am Coll Cardiol (2007) 0.85
Cost-effectiveness of apixaban compared with aspirin for stroke prevention in atrial fibrillation among patients unsuitable for warfarin. Circ Cardiovasc Qual Outcomes (2012) 0.84
Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable. Am J Cardiol (2012) 0.84
Effect of diuresis on P-wave duration and dispersion. Pharmacotherapy (2002) 0.83
Association between CHADS₂risk factors and anticoagulation-related bleeding: a systematic literature review. Mayo Clin Proc (2011) 0.83
Optimization of superior vena cava coil position and usage for transvenous defibrillation. Heart Rhythm (2007) 0.83
Recombinant human growth hormone in the treatment of patients with cystic fibrosis. Pediatrics (2010) 0.83
CRT-D Therapy in Patients with Decompensated NYHA Class-Four CHF. Cardiol Res Pract (2012) 0.83
Implantation of a biventricular pacing and defibrillator device via a persistent left superior vena cava. J Cardiovasc Med (Hagerstown) (2006) 0.83
An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence. Ann Noninvasive Electrocardiol (2006) 0.83
The use of protamine after radiofrequency catheter ablation: a pilot study. J Interv Card Electrophysiol (2007) 0.82
Impact of intravenous magnesium on post-cardiothoracic surgery atrial fibrillation and length of hospital stay: a meta-analysis. Ann Thorac Surg (2005) 0.82
Coronary sinus shocking lead as salvage in patients with advanced CHF and high defibrillation thresholds. Pacing Clin Electrophysiol (2010) 0.82
Impact of gender on statin efficacy. Curr Med Res Opin (2007) 0.81
Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects. Pharmacotherapy (2005) 0.81
Impact of magnesium sulfate on serum magnesium concentrations and intracellular electrolyte concentrations among patients undergoing radio frequency catheter ablation. Conn Med (2008) 0.81
Blowing a gasket. Time (2004) 0.81
Prolonged versus standard-duration venous thromboprophylaxis in major orthopedic surgery: a systematic review. Ann Intern Med (2012) 0.81
Masters of denial. Time (2003) 0.81
How Bill put the fizz in the fight against fat. Time (2006) 0.81
The congenital long QT syndrome and implications for young athletes. Med Sci Sports Exerc (2006) 0.81
Patient satisfaction with warfarin- and non-warfarin-containing thromboprophylaxis regimens for atrial fibrillation. J Investig Med (2013) 0.81
Impact of prophylactic amiodarone on length of hospital stay, stroke, and atrial fibrillation after cardiothoracic surgery. Pharmacotherapy (2005) 0.80
Short-term consequences of angiographically-confirmed coronary stent thrombosis. PLoS One (2013) 0.80
The relationship between statin use and atrial fibrillation. Curr Med Res Opin (2007) 0.80
Hemodynamic and electrocardiographic effects of short-term Ginkgo biloba. Ann Pharmacother (2003) 0.80
Magnesium adjunctive therapy in atrial arrhythmias. Pacing Clin Electrophysiol (2013) 0.80
Comparative effectiveness of combined pharmacologic and mechanical thromboprophylaxis versus either method alone in major orthopedic surgery: a systematic review and meta-analysis. Pharmacotherapy (2013) 0.80
Ineffective ICD therapy due to excessive alcohol and exercise. Pacing Clin Electrophysiol (2002) 0.80
What now? Our feverish planet badly needs a cure. Time (2007) 0.79
Outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery: a meta-analysis. Ann Pharmacother (2009) 0.79
Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy. Europace (2008) 0.79
Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis. Pharmacotherapy (2012) 0.79
The Angelina effect. Time (2013) 0.79
Is God in our genes? A provocative study asks whether religion is a product of evolution. Inside a quest for the roots of faith. Time (2004) 0.79
Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation. Ann Pharmacother (2007) 0.79
Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter. Am J Health Syst Pharm (2003) 0.79
Effects of intravenous magnesium sulfate on the QT interval in patients receiving ibutilide. Pharmacotherapy (2003) 0.79
Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter. Pacing Clin Electrophysiol (2007) 0.79
A hospital perspective on the cost-effectiveness of beta-blockade for prophylaxis of atrial fibrillation after cardiothoracic surgery. Clin Ther (2005) 0.79
Evaluation of the Charlson comorbidity index to predict early mortality in implantable cardioverter defibrillator patients. Ann Noninvasive Electrocardiol (2013) 0.78
Use of preoperative CHA2 DS2 -VASc score to predict the risk of atrial fibrillation after cardiothoracic surgery: a nested case-control study from the Atrial Fibrillation Suppression Trials (AFIST) I, II, and III. Pharmacotherapy (2013) 0.78
Thiazolidinedione use and post-operative atrial fibrillation: a US nested case-control study. Curr Med Res Opin (2007) 0.78
Effect of ascorbic acid on inflammatory markers after cardiothoracic surgery. Am J Health Syst Pharm (2011) 0.78
Effect of magnesium L-lactate on blood pressure in patients with an implantable cardioverter defibrillator. Ann Pharmacother (2009) 0.78
Effects of echinacea on electrocardiographic and blood pressure measurements. Am J Health Syst Pharm (2007) 0.78
Effect of aprotinin on the frequency of postoperative atrial fibrillation or flutter. Am J Health Syst Pharm (2005) 0.78
Response of the ECG to short-term diuresis in patients with heart failure. Ann Noninvasive Electrocardiol (2005) 0.77
The cruelest cut. Time (2005) 0.77
Young and bipolar. Time (2002) 0.77
Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery. Pharmacotherapy (2004) 0.77
Corrected QT in ventricular paced rhythms: what is the validation for commonly practiced assumptions? Cardiology (2015) 0.77
Prognostic impact of thyroid stimulating hormone levels in patients with cardiomyopathy. Conn Med (2013) 0.77
Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery. Pharmacotherapy (2006) 0.77
Cost effectiveness of ibutilide with prophylactic magnesium in the treatment of atrial fibrillation. Pharmacoeconomics (2004) 0.77
Electrocardiographic effects of an Ephedra-Free, multicomponent weight-loss supplement in healthy volunteers. Pharmacotherapy (2005) 0.77
A tale of two syndromes: Lyme disease preceding postural orthostatic tachycardia syndrome. Ann Noninvasive Electrocardiol (2014) 0.77
The healthcare utilization and cost of treating patients experiencing inappropriate implantable cardioverter defibrillator shocks: a propensity score study. Pacing Clin Electrophysiol (2014) 0.76
Medicating young minds. Time (2003) 0.76
Benefits and risks associated with beta-blocker prophylaxis in noncardiac surgery. Am J Health Syst Pharm (2010) 0.76
Beta-Blocker Variability in Treatment of Long QT Syndrome: What Is the Confounder? J Am Coll Cardiol (2015) 0.75